الفهرس 
Hair
ResultsOnly 14 pages are availabe for public view
 |  | from | 244 |  |  |
| | | from | 244 | | |
Abstract
Female hair loss is a stressful condition that diminishes body image satisfaction and directs patients to seek therapy. Hair loss has different forms and clinical presentations and it is an increasingly common complaint of dermatology clinic patients. While there are many potential diagnoses, the most frequently encountered is FPHL that is frequently referred to as androgenic alopecia; however, the role of androgens in this type of hair loss remains uncertain. Another common disease is TE, which results from an abrupt shift of large numbers of anagen hairs to telogen hairs on the scalp. This form of alopecia generally begins approximately 3 months after a major illness or other stress. Alopecia areata also is not uncommon disease of hair loss in females. Current strategies for the treatment of pattern hair loss are mainly focused on promoting cellular proliferation and differentiation during the hair growth cycle. The most commonly used medications for treatment of female alopecia are minoxidil and oral fenasteride. PRP is an autologous concentrate of human platelets in a small volume of plasma (approximately 150-400×103 cell/dL), containing high concentration of growth factors & cytokines.